Market openNon-fractional
Pharvaris/PHVS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Pharvaris
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .
Ticker
PHVS
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Leiden, Netherlands
Employees
83
Website
pharvaris.com
Pharvaris Metrics
BasicAdvanced
$991M
Market cap
-
P/E ratio
-$2.65
EPS
-3.10
Beta
-
Dividend rate
Price and volume
Market cap
$991M
Beta
-3.1
Financial strength
Current ratio
20.526
Quick ratio
20.112
Long term debt to equity
0.019
Total debt to equity
0.053
Management effectiveness
Return on assets (TTM)
-24.78%
Return on equity (TTM)
-43.52%
Valuation
Price to book
2.54
Price to tangible book (TTM)
2.54
Price to free cash flow (TTM)
-7.385
Growth
Earnings per share change (TTM)
-0.29%
3-year earnings per share growth
-20.42%
What the Analysts think about Pharvaris
Analyst Ratings
Majority rating from 7 analysts.
Pharvaris Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€0
NaN%
Net income
-€28M
-14.37%
Profit margin
0.00%
NaN%
Pharvaris Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-€0.63
-€0.58
-€0.76
-€0.52
-
Expected
-€0.65
-€0.60
-€0.53
-€0.56
-€0.55
Surprise
-3.06%
-4.11%
42.59%
-7.67%
-
Pharvaris News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pharvaris stock?
Pharvaris (PHVS) has a market cap of $991M as of July 05, 2024.
What is the P/E ratio for Pharvaris stock?
The price to earnings (P/E) ratio for Pharvaris (PHVS) stock is 0 as of July 05, 2024.
Does Pharvaris stock pay dividends?
No, Pharvaris (PHVS) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Pharvaris dividend payment date?
Pharvaris (PHVS) stock does not pay dividends to its shareholders.
What is the beta indicator for Pharvaris?
Pharvaris (PHVS) has a beta rating of -3.1. This means that it has an inverse relation to market volatility.
Buy or sell Pharvaris stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.